NFI-C2 negatively regulates α-sarcoglycan promoter activity in C2C12 myoblasts
- 2 July 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 319 (3) , 1032-1039
- https://doi.org/10.1016/j.bbrc.2004.05.074
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- zeta-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophyHuman Molecular Genetics, 2002
- Muscular dystrophies involving the dystrophin–glycoprotein complex: an overview of current mouse modelsCurrent Opinion in Genetics & Development, 2002
- The dystrophin–glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophiesMuscle & Nerve, 2001
- Overexpression of γ-Sarcoglycan Induces Severe Muscular DystrophyPublished by Elsevier ,2001
- Molecular basis of muscular dystrophiesMuscle & Nerve, 2000
- Sarcoglycans in muscular dystrophyMicroscopy Research and Technique, 2000
- Rescue of Skeletal Muscles of γ-Sarcoglycan- Deficient Mice with Adeno-Associated Virus-Mediated Gene TransferMolecular Therapy, 2000
- Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in CultureThe Journal of cell biology, 1998
- γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of DystrophinThe Journal of cell biology, 1998
- ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2DJournal of Biological Chemistry, 1997